Abstract:Osteoarthritis (OA) is a prevalent bone and joint disease characterized by degeneration. The dysregulation between chondrocyte synthesis and breakdown is a key factor in OA development. Targeting the degenerative changes in cartilage tissue degradation could be a potential treatment approach for OA. Previous research has established a strong link between autophagy and the regulation of chondrocyte functions. Activating autophagy has shown promise in mitigating cartilage tissue degeneration. Currently, osteoarthritis treatment primarily focuses on symptom management, as there is no definitive medication to stop disease progression. Previous studies have demonstrated that luteolin, a flavonoid present in Chinese herbal medicine, can activate autophagy and reduce the expression of MMP1 and ADAMTS-5. This study utilized an in vitro osteoarthritis model with chondrocytes stimulated by IL-1β, treated with varying concentrations of luteolin. Treatment with luteolin notably increased the levels of synthesis factors Aggrecan and Collagen II, while decreasing the levels of decomposition factors MMP-1 and ADAMTS-5. Moreover, inhibition of autophagy by Chloroquine reversed the imbalances in chondrocyte activities induced by IL-1β. In an in vivo model of knee osteoarthritis induced by medial meniscal instability (DMM), luteolin was administered as a therapeutic regimen. After 12 weeks, knee cartilage tissues from mice were analyzed. Immunofluorescence and immunohistochemical staining revealed a decrease in P62 expression and an increase in Beclin-1 in the cartilage tissues. Additionally, cartilage wear in the knee joints of mice was alleviated by safranin O and fast green staining. Our study findings underscore the significant role of luteolin in effectively rebalancing chondrocyte activities disrupted by IL-1β. Our results strongly indicate that luteolin has the potential to be developed as a novel therapeutic agent for the treatment of osteoarthritis, offering promising prospects for future drug development.

Regulating lipid metabolism in osteoarthritis: a complex area with important future therapeutic potential

Lubricin: a novel potential biotherapeutic approaches for the treatment of osteoarthritis

Systemic and joint adipose tissue lipids and their role in osteoarthritis

Role of adiponectin in osteoarthritis

Circfam160a2 Promotes Mitochondrial Stabilization and Apoptosis Reduction in Osteoarthritis Chondrocytes by Targeting Mir-505-3p and SIRT3.

The dysregulated autophagy in osteoarthritis: Revisiting molecular profile

Glycolysis: an emerging regulator of osteoarthritis

Research progress on role of energy metabolism in osteoarthritis

Lipid peroxidation in osteoarthritis: focusing on 4-hydroxynonenal, malondialdehyde, and ferroptosis

Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis—a Complex Field with Significant Potential for Future Treatments

Metabolic triggered inflammation in osteoarthritis

Enhancing intracellular cholesterol efflux in chondrocytes alleviates osteoarthritis progression

Enhancement of Intracellular Cholesterol Efflux in Chondrocytes Leading to Alleviation of Osteoarthritis Progression

The role of the sirtuin family in cartilage and osteoarthritis: molecular mechanisms and therapeutic targets

Luteolin regulating synthesis and catabolism of osteoarthritis chondrocytes via activating autophagy

Oleic and Linoleic Acids Promote Chondrocyte Apoptosis by Inhibiting Autophagy Via Downregulation of SIRT1/FOXO1 Signaling.

The Role of Mitochondrial Metabolism, AMPK-SIRT Mediated Pathway, LncRNA and MicroRNA in Osteoarthritis

Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging

MicroRNA-10a-3p Improves Cartilage Degeneration by Regulating CH25H-CYP7B1-RORα Mediated Cholesterol Metabolism in Knee Osteoarthritis Rats

Identification and validation of biomarkers related to lipid metabolism in osteoarthritis based on machine learning algorithms